Axial spondyloarthritis and response to TNF inhibitors in patients
4.7
$ 16.50
In stock
(144)
Product Description
Therapeutic potential of TNFα inhibitors in chronic inflammatory
Treatment Efficacy, Rheumatology PsA
Predictive Factors of Clinical Response of Infliximab Therapy in
Diagnosis and management of axial spondyloarthritis in primary
VisualAbstract: Ixekizumab for patients with non-radiographic
:max_bytes(150000):strip_icc()/zhansen-5192560_Final2-b2f1a65d0f1a4031825558cba52fa207.jpg "Axial spondyloarthritis and response to TNF inhibitors in patients")
Biologics for Non-Radiographic Axial Spondyloarthritis: Getting
Disease Control Data, nr-axSpA
Little to no benefit' in TNF inhibitor dose reduction for axial
ASAS 20/40 responses in anti-TNF-naïve and anti-TNF-IR subjects at
PDF) ASDAS, BASDAI and different treatment responses and their
Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and
Figure 1 from Tumor necrosis factor-α (TNFα) inhibitors in the
Related products
You may also like
